Fig 2: Cas13d-mediated KDM5B knockdown in porcine oocytes. (A) Schematic diagram of microinjection in MII oocytes. (B) Expression of Cas13d transcript in blastocysts after injection of Cas13d mRNA with or without gRNA was determined by semi-quantitative PCR. (C) GFP expression in two-cell embryos and blastocysts after injection of Cas13d mRNA with or without gRNA. Scale bar, 40 μm. (D) Semi-quantitative PCR analysis of expression of KDM5B after injection Cas13d with or without gRNA in two-cell embryos is shown on the left. The quantitative result is shown on the right. (E, F, G and H) Immunofluorescence staining of H3K4me3 and H3K27me3 in two-cell embryos (E and F) and blastocysts (G and H) after injection of Cas13d RNA with or without gRNA. The quantitative results are shown on the right. At least 10 embryos were counted for each group. Scale bar, 40 μm. (I) The cleavage rate in both groups with or without injection. (J and K) The blastocyst rate in both groups with or without injection. A representative picture of embryos developed to the blastocyst stage in both groups is shown in K. (L) Proportion of blastocysts with different cell number was counted after injection of Cas13d with or without gRNA. (M) The proportion of blastocysts with over 30 cells was compared after injection Cas13d and gRNA vs Cas13d only. (N and O) Semi-quantitative PCR analysis of the expression of HOX genes and TET genes in two-cell embryos.

Fig 3: Knockdown of KDM5B resulted in the abundance change of histone modifications and the arrest of PEF cell proliferation and cell cycle. (A, B, C, D, E and F) Immunofluorescence staining of H3K4me3 (A), H3K27me3 (B), H3K9me3 (C), H3K4ac (D), H4K8ac (E), and H4K12ac (F)in PEF cells transfected with Cas13d and gRNA4 targeting KDM5B or Cas13d only. The quantitative analysis of fluorescence intensity is shown on the right. Data are presented as the mean ± s.e.m.; *P < 0.05. Scale bar, 40 μm. At least 10 randomly selected fields were counted for each group. (G) Cell proliferation analysis of PEF cells transfected with Cas13d and gRNA4 (Cas13d only as control). *P < 0.05. 450 nm, the optical density (OD) absorbance at the wavelength of 450nm. (H) Cell cycle analysis of PEF cells transfected with Cas13d and gRNA4 (Cas13d only as control.) *P < 0.05.

Fig 4: Cas13d-mediated continuous knockdown of KDM5B in PEF cells. (A) Schematic representation of the design of CRISPR/Cas9-mediated, HR-independent integration of Cas13d and gRNA. Exons of UCP1 are shown in yellow rectangle. The blue lightning bolt in exon2 represents the Cas9-UCP1-gRNA target site, and the red boxes represent UCP1-gRNA. The U6-pre-gRNA-CAG-Cas13d-GFP expression plasmid is shown on the upper left, and the Cas9-UCP1-gRNA expression plasmid is shown on the upper right. The bottom showed forward integration of Cas13d and gRNA in UCP1. Three pairs of primers were designed for genotyping. F2/R2 and F3/R3 were designed for genotyping the 5’ and 3’ junctions in the transgenic colonies, respectively. F1/R1 were designed for detecting the integration of the UCP1-U6-pre-gRNA-CAG-Cas13d-GFP-UCP1 expression plasmid. (B) Confirmation of the successful construction of UCP1-U6-pre-gRNA-CAG-Cas13d-GFP-UCP1 and Cas9-UCP1-gRNA vector by Sanger sequencing. (C) Schematic diagram of the process to generate Cas13d-gRNA knockin cell colonies. (D) Genotyping results of the positive knockin colony by PCR (left) and Sanger sequencing (right). The primers used for PCR is indicated in A. (E) Semi-quantitative PCR analysis of the expression of Cas13d from the WT and KI cell at different time points post-transfection. (F) The GFP expression in the positive KI colony was detected by immunofluorescence imaging. Scale bar, 40 μm. (G) Quantitative PCR analysis of the expression of KDM5B in the KI colony against WT in different times.